このエントリーをはてなブックマークに追加
ID 62226
JaLCDOI
フルテキストURL
75_3_315.pdf 1.99 MB
著者
Wada, Riho Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Fujiwara, Masaki Department of Neuropsychiatry, Okayama University Hospital
Yamada, Yuto Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Nakaya, Naoki Department of Health Sciences, Saitama Prefectural University
Fujimori, Maiko Division of Health Care Research, Behavioral Sciences and Survivorship Research Group, National Cancer Center
So, Ryuhei Okayama Psychiatric Medical Center
Kodama, Masafumi Okayama Psychiatric Medical Center
Higuchi, Yuji Care of Your Mind, Taiyo Hills Hospital
Kakeda, Kyoko Department of Neuropsychiatry, Kochi Medical School, Kochi University
Uchitomi, Yosuke Innovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital
Yamada, Norihito Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Inagaki, Masatoshi Department of Psychiatry, Faculty of Medicine, Shimane University
抄録
It is necessary to assess functional impairment when treating schizophrenia. The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) has been adopted as a measure of functional disability in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. This study was a secondary analysis from a cross-sectional study of health-related behaviors among patients with schizophrenia. We examined the validity and reliability of the Japanese version of the 12-item WHODAS 2.0 when self-administered by such patients. Participants were 350 outpatients with schizophrenia from a psychiatric hospital. The standard six-factor structure of the WHODAS 2.0 showed a good fit for these participants. The Cronbach’s alpha coefficient was 0.858, showing good internal consistency. The WHODAS 2.0 showed moderate correlations with the modified Global Assessment of Functioning and Kessler 6 scales (r=−0.434 and 0.555, respectively). The results of this study show that the Japanese version of the 12-item self-administered WHODAS 2.0 has good internal consistency and convergent validity among patients with schizophrenia. Further exploration of the usefulness of WHODAS 2.0 in clinical settings is needed.
キーワード
disability
schizophrenia
validity
reliability
WHODAS 2.0
Amo Type
Original Article
出版物タイトル
Acta Medica Okayama
発行日
2021-06
75巻
3号
出版者
Okayama University Medical School
開始ページ
315
終了ページ
322
ISSN
0386-300X
NCID
AA00508441
資料タイプ
学術雑誌論文
言語
英語
著作権者
CopyrightⒸ 2021 by Okayama University Medical School
論文のバージョン
publisher
査読
有り
PubMed ID
NAID